Medline Inc 's Cash & cash equivalent grew by 19.72 % in the Q2 2026 sequentially, faster than Current Liabilities, this led to improvement in Medline Inc 's Quick Ratio to 0.96 a new company high.

Within Medical Equipment & Supplies industry 110 other companies have achieved higher Quick Ratio than Medline Inc in second quarter 2026. While Quick Ratio total ranking in the second quarter 2026 has deteriorated compared to the prior quarter from 1218 to 2006.

Explain Quick Ratio?
How much Cash & cash equivalents MDLN�s has?
What are MDLN�s Current Liabilities?

Select the Comparisons :

None ▼

Select the Ratio:

Quick Ratio ▼

None ▼

Quick Ratio ▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

MDLN Quick Ratio	(Jun 27 2026) Q2	(Mar 28 2026) Q1	(Dec 31 2025) Q4	(Dec 31 2024) Q2	Q1
Y / Y Current Liabilities Change	-	-	-	-	-
Y / Y Cash & cash equivalent Change	-	-	-	-	-
Quick Ratio MRQ	0.96	0.88	0.78	0.08	-
MDLN's Total Ranking	# 2006	# 1218	# 0	#	#
Seq. Current Liabilities Change	10.53 %	1.85 %	-1.46 %	-	-
Seq. Cash & cash equivalent Change	19.72 %	15.32 %	874.37 %	-	-

Quick Ratio second quarter 2026 Company Ranking
Within:	No.
Medical Equipment & Supplies Industry	# 111
Healthcare Sector	# 635
Overall Market	# 2006

Quick Ratio Statistics
High	Average	Low
0.96	0.67	0.08
(Jun 27 2026)		(Dec 31 2024)

Financial Statements
Medline Inc 's Current Liabilities	$ 2,803 Millions	Visit MDLN's Balance sheet
Medline Inc 's Cash & cash equivalent	$ 2,677 Millions	Visit MDLN's Balance sheet
Source of MDLN's Sales		Visit MDLN's Sales by Geography

Cumulative Medline Inc 's Quick Ratio

MDLN's Quick Ratio for the trailling 12 Months

MDLN Quick Ratio	(Jun 27 2026) 12 Months	(Mar 28 2026) 12 Months	(Dec 31 2025) 12 Months	(Dec 31 2024) 12 Months	12 Months
Y / Y Current Liabilities TTM Growth	-	-	-	-	-
Y / Y Cash & cash equivalent TTM Growth	-	-	-	-	-
Quick Ratio TTM	0.68	0.58	0.43	0.08	-
Total Ranking TTM	#	#	#	#
Seq. Current Liabilities TTM Growth	37.11 %	50.55 %	98.54 %	-	-
Seq. Cash & cash equivalent TTM Growth	61.2 %	104.58 %	974.37 %	-	-

Quick ratio ranking by company, industry and sector >> Back to MDLN Financial Strength Comparisons >> Go to Compare MDLN Quick Ratio to its Competitors

On the trailing twelve months basis MDLN Cash & cash equivalent increased by 19.72 % in Q2 2026 year on year, faster than Current Liabilities, this led to increase in in Medline Inc 's Quick Ratio to 0.68, above MDLN average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 110 other companies have achieved higher Quick Ratio than Medline Inc . While overall ranking is unchanged compared to the previous 12 months at no. 0.

Explain Quick Ratio?
How much Cash & cash equivalents MDLN�s has?
What are MDLN�s Current Liabilities?

TTM Quick Ratio Company Ranking
Within:	No.
Within the Medical Equipment & Supplies Industry	# 111
Healthcare Sector	# 635
Within the Market	# 2006

trailing twelve months Quick Ratio Statistics
High	Average	Low
0.96	0.67	0.08
(Jun 27 2026)		(Dec 31 2024)

Companies with similar Quick Ratio in the quarter ending Jun 27 2026, within Medical Equipment & Supplies Industry	Quick Ratio	Jun 27 2026 MRQ Cash & cash equivalent	Jun 27 2026 MRQ Current Liabilities
Co diagnostics Inc	2.55	$ 7.299 Millions	$ 2.863 Millions
Staar Surgical Co	2.47	$ 181.489 Millions	$ 73.394 Millions
Electromed Inc	2.35	$ 20.450 Millions	$ 8.714 Millions
EBR Systems, Inc.	2.18	$ 113.533 Millions	$ 52.023 Millions
Medinotec Inc	2.15	$ 2.519 Millions	$ 1.171 Millions
Atricure Inc	2.05	$ 167.786 Millions	$ 81.916 Millions
Tactile Systems Technology Inc	1.83	$ 69.853 Millions	$ 38.253 Millions
Tandem Diabetes Care Inc	1.80	$ 455.996 Millions	$ 253.005 Millions
Inspire Medical Systems inc	1.79	$ 127.761 Millions	$ 71.282 Millions
Warby Parker Inc	1.79	$ 292.674 Millions	$ 163.480 Millions
Capsovision Inc	1.76	$ 9.077 Millions	$ 5.158 Millions
Anika Therapeutics Inc	1.73	$ 38.412 Millions	$ 22.147 Millions
Genedx Holdings Corp	1.71	$ 132.548 Millions	$ 77.648 Millions
Beta Bionics Inc	1.70	$ 44.318 Millions	$ 26.017 Millions
Merit Medical Systems Inc	1.70	$ 450.906 Millions	$ 264.933 Millions
Seastar Medical Holding Corp	1.60	$ 6.959 Millions	$ 4.353 Millions
Tela Bio Inc	1.59	$ 30.424 Millions	$ 19.080 Millions
Conexeu Sciences Inc	1.55	$ 1.971 Millions	$ 1.272 Millions
Inogen Inc	1.49	$ 105.539 Millions	$ 70.864 Millions
Dariohealth Corp	1.49	$ 14.254 Millions	$ 9.578 Millions
Myomo Inc	1.45	$ 15.686 Millions	$ 10.805 Millions
Envoy Medical Inc	1.43	$ 19.679 Millions	$ 13.807 Millions
Nephros Inc	1.40	$ 4.697 Millions	$ 3.344 Millions
Envista Holdings Corporation	1.39	$ 1,125.600 Millions	$ 807.300 Millions
Medtronic Plc	1.36	$ 16,068.000 Millions	$ 11,799.000 Millions
Sanara Medtech Inc	1.31	$ 16.421 Millions	$ 12.494 Millions
Globus Medical Inc	1.24	$ 595.142 Millions	$ 479.347 Millions
Lucid Diagnostics Inc	1.21	$ 33.404 Millions	$ 27.516 Millions
Sintx Technologies Inc	1.21	$ 3.590 Millions	$ 2.977 Millions
Vaso Corporation	1.17	$ 38.291 Millions	$ 32.863 Millions

Date modified: 2026-09-08T15:11:45+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.